Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
iTeos Therapeutics Raises US$4 Million In Series A Financing 10
Partnerships 12
Ludwig Institute for Cancer Research and Cancer Research Institute Partner with Targovax 12
Immune Design Enters Into Research Agreement With Cancer Research Institute And Ludwig Institute For Cancer Research 13
4-Antibody And Ludwig Institute Enter Into Agreement With Recepta Biopharma For Oncology Research 15
Medimmune Enters Into Research Agreement With Cancer Research Institute And Ludwig Institute for Cancer Research 16
Licensing Agreements 18
iOx Therapeutics Enters into Licensing Agreement with Ludwig Institute 18
Agenus Enters into Licensing Agreement with Ludwig Institute 19
iTeos Therapeutics Receives Rights to IDO1 and TDO2 from Ludwig Institute for Cancer Research 20
Ludwig Institute For Cancer Research Ltd – Key Competitors 21
Ludwig Institute For Cancer Research Ltd – Key Employees 22
Ludwig Institute For Cancer Research Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Government and Public Interest 25
Mar 15, 2018: Ludwig study extends the potential for personalized immunotherapy to a large variety of cancers 25
Jan 29, 2018: Ludwig researchers devise and test novel combination therapy for advanced melanoma 27
Nov 23, 2017: Ludwig Researchers Unravel Novel Mechanism By Which Tumors Grow Resistant To Radiotherapy 28
Sep 19, 2017: Ludwig Scientists Discover Complex Axis Of Immune Suppression Exploited By Cancers 29
Jun 22, 2017: Presence of protein important clue to tumour regression in neuroblastoma 31
Jun 22, 2017: The presence of the protein KIF1Bβ can play a central role for the outcome of a neuroblastoma diagnosis 32
May 12, 2017: Ludwig researchers identify counterintuitive approach to treating a brain cancer 33
Jan 16, 2017: Ludwig Study Reveals Why Cancer Cells Spread Within The Body 34
Product News 36
Dec 19, 2017: Ludwig Researchers Uncover Mechanism Behind a Metabolic Vulnerability of Certain Breast Cancers 36
Nov 10, 2017: Ludwig Researchers Uncover Novel Mechanism by Which Tumors Evade a Variety of Cancer Immunotherapies 38
Mar 15, 2017: Immunotherapy may help treat kids’ brain tumors, preliminary Stanford study shows 40
Mar 02, 2017: A Vulnerability in Triple-negative Breast Cancer Could Improve Treatment Outcomes 41
Other Significant Developments 43
Mar 20, 2018: Six discoveries that greatly improved the treatment of ovarian cancer 43
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ludwig Institute For Cancer Research Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
iTeos Therapeutics Raises US$4 Million In Series A Financing 10
Ludwig Institute for Cancer Research and Cancer Research Institute Partner with Targovax 12
Immune Design Enters Into Research Agreement With Cancer Research Institute And Ludwig Institute For Cancer Research 13
4-Antibody And Ludwig Institute Enter Into Agreement With Recepta Biopharma For Oncology Research 15
Medimmune Enters Into Research Agreement With Cancer Research Institute And Ludwig Institute for Cancer Research 16
iOx Therapeutics Enters into Licensing Agreement with Ludwig Institute 18
Agenus Enters into Licensing Agreement with Ludwig Institute 19
iTeos Therapeutics Receives Rights to IDO1 and TDO2 from Ludwig Institute for Cancer Research 20
Ludwig Institute For Cancer Research Ltd, Key Competitors 21
Ludwig Institute For Cancer Research Ltd, Key Employees 22
Ludwig Institute For Cancer Research Ltd, Other Locations 23
Ludwig Institute For Cancer Research Ltd, Subsidiaries 24
List of Figures
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ludwig Institute For Cancer Research Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8